past
decad
number
countri
report
falsifi
fake
spuriousfals
labeledcounterfeit
medicin
type
quantiti
fraudul
drug
distribut
increas
greatli
obstacl
combat
falsifi
pharmaceut
includ
lack
consensu
definit
pauciti
reliabl
scalabl
technolog
detect
fake
reach
patient
poor
global
nation
leadership
account
system
combat
scourg
defici
manufactur
regulatori
challeng
especi
china
india
fake
product
often
origin
major
need
improv
qualiti
world
medicin
fall
three
main
area
research
develop
compar
accur
afford
tool
identifi
highqual
drug
level
distribut
intern
convent
nation
legisl
facilit
product
util
highqual
drug
protect
countri
crimin
neglig
make
distribut
sell
lifethreaten
product
highli
qualifi
wellsupport
intern
scienc
public
health
organ
establish
standard
drugqual
surveil
train
program
like
us
food
drug
administr
leadership
would
give
authorit
guidanc
countri
cooper
nation
medic
regulatori
agenc
pharmaceut
compani
intern
agenc
urgent
interest
invest
ensur
patient
throughout
world
access
good
qualiti
medicin
organ
would
also
advoc
strongli
includ
target
achiev
good
qualiti
medicin
unit
nation
millennium
develop
goal
sustain
develop
goal
malaria
devast
ill
particularli
young
children
pregnant
women
tropic
countri
recent
review
report
activ
pharmaceut
ingredi
api
absent
onethird
close
antimalari
drug
sampl
test
pharmaci
seven
southeast
asian
subsaharan
african
countri
alleg
artemisinincontain
drug
falsifi
outright
fake
wide
varieti
falsifi
brand
name
gener
medicin
even
falsifi
raw
ingredi
sever
essenti
pharmaceut
found
rich
poor
countri
drug
often
use
acut
ill
patient
mani
would
die
suffer
prolong
ill
without
proper
treatment
addit
patient
loss
confid
healthcar
deliveri
system
microbi
resist
drug
may
develop
spread
medicin
contain
subtherapeut
dose
api
increas
global
scientif
public
awar
epidem
proport
spread
problem
reflect
number
articl
fake
drug
cite
pubm
recent
pauciti
report
pharmaceut
compani
type
quantiti
drug
fraudul
compound
transfer
crimin
data
emerg
pharmaceut
secur
institut
psi
notforprofit
membership
organ
pharmaceut
secur
director
indic
larg
number
compani
product
countri
target
instanc
sinc
pfizer
pharmaceut
pfizer
global
secur
new
york
ny
identifi
rapidli
increas
number
falsifi
product
countri
report
falsifi
drug
breach
legitim
suppli
chain
nation
entri
point
tabl
increas
pfizer
product
erectil
dysfunct
frequent
falsifi
product
target
patient
alzheim
diseas
cancer
high
cholesterol
hypertens
malaria
anxieti
disord
facil
fake
drug
made
compound
discov
moldi
wall
dirti
equip
infest
rodent
insect
figur
falsifi
creat
product
visual
indistinguish
genuin
product
clearli
demonstr
crimin
intent
deceiv
increasingli
recogn
problem
virtual
contin
pandem
defin
epidem
occur
wide
area
cross
intern
boundari
usual
affect
larg
number
peopl
definit
despit
increas
awar
fraudul
drug
epidem
effort
quantifi
stop
peril
stymi
multipl
obstacl
least
agreement
definit
poor
qualiti
drug
includ
substandard
spuriousfals
labeledfalsifiedcounterfeit
ssffc
medic
product
falsifi
also
commonli
call
fake
counterfeit
product
intent
fraudul
produc
contain
api
incorrect
dose
api
incorrect
api
substandard
medicin
caus
unintent
neglig
error
manufactur
degrad
manufactur
result
insuffici
api
poor
dissolut
properti
degrad
product
nomenclatur
use
world
health
organ
world
trade
organ
unit
nation
un
offic
drug
crime
interpol
other
confus
henc
use
term
agre
upon
also
properli
manufactur
medicin
unlaw
reason
apart
qualiti
unregist
compani
brand
gener
medicin
reason
theft
accident
intent
divers
legal
requir
market
author
countri
regul
import
sold
medicin
infring
trademark
legal
product
rel
littl
known
medicin
expir
repackag
new
date
topic
along
divert
product
beyond
realm
articl
articl
focus
mainli
medic
public
health
consider
falsifi
medicin
particularli
widespread
lowand
middleincom
countri
although
increas
report
detect
varieti
fake
drug
around
world
paradox
virtual
report
middleor
highincom
countri
quantifi
state
poor
qualiti
medicin
anecdot
case
citat
govern
hamper
confus
array
expens
detect
technolog
function
nation
regulatori
author
exist
lowincom
nation
lack
train
staff
suitabl
equip
laboratori
test
drug
qualiti
central
peripher
pharmaci
market
furthermor
variabl
absenc
nation
intern
crimin
statut
lack
intern
agreement
traffick
poor
qualiti
medicin
inadequ
punish
convict
offend
reflect
weak
legal
framework
confront
drug
fraud
one
biggest
obstacl
provis
qualityassur
pharmaceut
lack
effect
manufactur
regulatori
qualiti
process
india
china
global
public
health
agenc
includ
provid
foundat
research
institut
contribut
develop
advocaci
campaign
address
falsifi
medicin
particularli
china
campaign
call
fight
fake
step
toward
rais
awar
problem
legal
action
follow
along
public
polit
awar
us
institut
medicin
iom
publish
report
counter
problem
falsifi
substandard
drug
iom
recommend
stem
global
trade
product
laudabl
advis
us
food
drug
administr
fda
nation
institut
standard
technolog
us
intern
pharmaceut
financ
agenc
activ
involv
set
standard
financ
improv
yet
report
fall
far
short
make
strong
call
standard
agreedupon
qualiti
assess
technolog
intern
law
convent
activist
intern
recogn
lead
organ
three
essenti
stop
mani
health
threat
fake
drug
global
leadership
date
devolv
part
un
offic
drug
crime
interpol
divers
mission
respons
limit
author
collabor
fund
network
cultur
languag
organ
lead
assert
three
area
list
intern
convent
improv
nation
regul
like
endur
valu
concert
effect
leadership
innov
focu
action
tie
drug
qualiti
must
public
individu
health
strengthen
nation
capac
improv
health
citizen
detect
method
technolog
major
hindranc
understand
type
name
extent
amount
poor
qualiti
drug
nation
global
lack
agreedupon
field
survey
approach
avail
lowcost
tool
detect
classifi
bad
drug
quickli
point
entri
countri
public
privat
pharmaci
health
unit
publish
draft
guidelin
survey
medicin
qualiti
current
revis
two
level
drug
qualiti
test
exist
method
useabl
field
quick
inexpens
easi
use
teach
method
target
mainli
examin
packag
detect
drug
content
technolog
requir
laboratori
equip
exhaust
chemic
analysi
approach
summar
tabl
deriv
iom
report
recent
analysi
green
other
center
diseas
control
prevent
refer
laboratori
within
method
numer
tool
prototyp
use
new
one
test
current
technolog
field
use
reli
visual
packag
inspect
lot
number
report
via
mobil
phone
thinlay
chromatographi
colorimetr
test
simplifi
spectroscop
method
ga
liquid
chromatographi
mass
spectrometri
advanc
complex
techniqu
investig
drug
qualiti
central
laboratori
qualit
semiquantit
test
api
substitut
proper
manufactur
control
dissolut
studi
pharmacokinet
equival
suppli
chain
integr
promis
recent
develop
us
pharmacopeia
promot
qualiti
medicin
pqm
program
sever
african
asian
latin
american
countri
use
minilab
global
pharma
health
fund
ev
giessen
germani
train
program
support
us
agenc
intern
develop
usaid
presid
malaria
initi
pmi
train
sever
hundr
person
rapid
chemic
analysi
drug
taken
public
privat
pharmaci
stock
major
refer
train
center
recent
open
accra
ghana
usaid
us
pharmacopeia
support
referr
test
region
train
center
import
also
develop
counterfeit
detect
cd
us
food
drug
administr
forens
chemistri
center
cincinnati
oh
promis
handheld
electron
devic
peripher
use
detect
fake
packag
point
sale
imag
video
suspect
sampl
fda
skoll
foundat
partner
support
expans
test
use
devic
recommend
precertif
essenti
diagnost
drug
vaccin
requir
specif
region
global
control
elimin
erad
program
campaign
inform
need
confirm
precertif
product
occur
pmi
global
fund
fight
aid
tuberculosi
malaria
product
purchas
un
intern
children
emerg
fund
unicef
essenti
drug
design
also
target
special
vigil
qualiti
assur
mechan
independ
agenc
inventori
perform
compar
qualiti
assess
packag
drugtest
devic
made
recommend
countri
use
object
comparison
need
divers
field
method
term
accuraci
reliabl
cost
equip
suppli
level
train
need
eas
use
spare
part
avail
mainten
requir
simplifi
standard
survey
protocol
method
sampl
drug
countri
entri
point
seaport
airport
road
major
pharmaci
depot
health
unit
public
privat
hospit
clinic
peripher
distribut
site
district
villag
pharmaci
individu
vendor
also
need
lowcost
portabl
detect
tool
would
empow
pharmaceut
inspector
numer
countri
oversight
medicin
suppli
result
would
avail
promptli
rather
delay
sampl
sent
nation
intern
laboratori
occur
lament
interv
sever
year
occur
time
specimen
collect
time
result
avail
need
take
action
ideal
central
refer
laboratori
vet
fda
anoth
agenc
would
back
spot
check
random
sampl
pharmaceut
peripheri
good
qualiti
medicin
law
falsifi
medicin
ultim
problem
impact
public
health
solut
need
reflect
variou
incent
either
via
financi
gain
avoid
punish
multisectori
effort
essenti
take
account
illeg
market
interwoven
world
trade
agreement
busi
model
associ
legal
ramif
global
enlarg
intern
trade
medicin
exampl
india
export
us
billion
pharmaceut
among
import
export
drug
api
drug
unit
state
import
foreign
countri
intern
law
convent
substandard
falsifi
medicin
would
address
regulatori
crimin
intern
govern
challeng
simultan
technic
legal
financi
mechan
would
convent
work
nation
benefit
would
bring
convent
would
provid
four
legal
underpin
exist
togeth
would
advanc
patient
safeti
access
qualiti
medicin
first
convent
would
defin
variou
sort
wrong
medicin
accur
therebi
avoid
misunderstand
caus
today
problemat
vagu
terminolog
eg
countri
seiz
good
qualiti
gener
medicin
counterfeit
second
convent
would
promot
requir
signatori
countri
enact
nation
law
design
wrong
actssuch
intent
manufactur
traffick
sell
falsifi
medicinesa
crimin
offenc
attend
oblig
alert
healthcar
worker
prosecut
extradit
offend
justic
promptli
third
convent
would
provid
legal
institut
framework
particip
countri
agre
implement
evolv
converg
standard
medicin
regul
reduc
poor
qualiti
medicin
intern
trade
fourth
lower
incom
countri
particularli
convent
would
contain
mechan
financi
technic
assist
join
local
region
network
action
would
help
build
nation
region
medicin
regulatori
author
mra
point
patient
access
qualiti
medicin
protect
said
establish
recommend
code
practic
nonbind
soft
law
better
intern
norm
regul
bind
hard
law
disagre
soft
law
regard
control
current
fakedrug
pandem
preced
use
intern
law
way
treati
intern
crimin
counterfeit
banknot
provid
analog
falsifi
medicin
health
field
treati
specif
address
illicit
traffic
certain
narcot
drug
treati
prevent
harmparticularli
framework
convent
tobacco
control
associ
protocol
stanch
illicit
trade
convent
brought
us
million
new
fund
global
tobaccocontrol
effort
demonstr
intern
law
need
compet
resourc
increas
un
offic
drug
crime
develop
draft
model
legisl
provis
fraudul
medic
product
sever
year
agreement
final
text
focu
appear
crimin
judici
issu
challeng
ahead
inform
accru
larg
quantiti
falsifi
drug
manufactur
asian
countri
china
india
two
largest
produc
good
qualiti
drug
vaccin
mani
purchas
fund
usaid
unicef
global
fund
fight
aid
tuberculosi
malaria
organ
chariti
nation
agenc
global
diseas
control
erad
program
howev
accord
world
custom
organ
unlaw
drug
sort
confisc
worldwid
manufactur
india
china
respect
circuit
travel
itinerari
fake
medicin
trace
across
contin
unsuspect
recipi
countri
assum
bona
fide
origin
particularli
heinou
exampl
multipl
instanc
product
market
intern
travel
falsifi
bevacizumab
avastin
cancer
medicin
fake
drug
close
match
appear
real
medicin
test
indic
salt
starch
variou
clean
solvent
instead
activ
ingredi
result
endophthalm
internet
open
unregul
opportun
crimin
promot
sell
fake
drug
unsuspect
vulner
popul
often
age
other
seek
conveni
low
cost
recent
survey
onlin
pharmaci
found
oper
outsid
legal
regul
larg
percentag
close
oper
within
year
oper
fda
organ
particip
interpol
annual
intern
action
oper
pangea
shutdown
illeg
pharmaci
websit
sell
potenti
counterfeit
illeg
medic
product
illeg
websit
close
one
week
seizur
us
million
pharmaceut
worldwid
leadership
collabor
nation
strengthen
arguabl
major
obstacl
solv
problem
poor
qualiti
medicin
lack
clearli
identifi
lead
organ
plan
action
develop
concert
countri
pharmaceut
compani
multin
corpor
innovatorbiotechnolog
enterpris
nation
intern
agenciesand
sens
urgenc
implement
plan
resourc
partnersinclud
pharmaceut
compani
lowincom
countri
estim
countri
inadequ
medicin
regul
author
mra
none
moreov
found
african
mra
lack
capac
undertak
medicin
regulatori
function
therefor
guarante
qualiti
efficaci
safeti
medicin
new
partnership
africa
develop
found
either
limit
declin
govern
fund
mra
east
african
commun
partner
state
mani
look
leadership
given
success
implement
public
health
treati
tobacco
control
howev
argu
un
system
includ
poorli
suit
leadership
role
spars
technic
expertis
product
manufactur
qualiti
system
un
agenc
beholden
member
state
regul
enforc
anyth
easili
especi
india
china
regard
could
serv
role
partner
rather
leader
recent
revit
rapid
alert
program
begun
track
trace
poor
qualiti
drug
report
voluntarili
member
countri
rapid
alert
notic
publish
period
indic
fake
drug
type
lot
number
quantiti
product
place
detect
strong
action
countri
stem
tide
shown
rwanda
cambodia
although
uniqu
situat
major
multisectori
engag
exist
countri
one
solut
creation
region
harmon
network
address
element
drug
registr
tie
region
econom
commun
african
medicin
registr
harmon
initi
one
exampl
network
un
offic
drug
crime
unodc
also
made
recent
attempt
facilit
intern
cooper
falsifi
medicin
one
propos
trilater
coalit
unodc
interpol
still
activ
transpar
support
fda
drug
compani
individu
countri
partner
need
fda
may
qualifi
leadership
organ
base
technic
expertis
global
influenc
mechan
train
technic
staff
regul
product
improv
manufactur
practic
stop
crimin
product
need
assur
good
suppli
medicin
given
problem
substandard
falsifi
medicin
approach
primarili
public
health
equiti
perspect
import
negoti
way
forward
led
ministri
health
along
minist
financ
trade
respect
legitim
intellectu
properti
right
could
lead
organ
curb
spread
epidem
falsifi
pharmaceut
abil
take
assert
action
strengthen
revis
intern
health
regul
director
gener
conven
emerg
committe
respons
public
health
emerg
done
recent
influenza
pandem
middl
east
respiratori
syndrom
merscov
polio
crise
ebola
epidem
illicit
drug
traffick
emerg
drug
qualiti
secur
act
sign
law
presid
obama
outlin
step
build
electron
system
identifi
trace
certain
prescript
drug
unit
state
result
system
await
final
millennium
develop
goal
mdg
revis
includ
measur
object
good
qualiti
drug
encourag
nation
establish
baselin
statu
achiev
target
particularli
essenti
drug
establish
mdg
target
sustain
develop
goal
sdg
help
greatli
solv
poor
qualiti
drug
epidem
applic
avail
technolog
good
pharmaceut
vigil
govern
one
incent
would
transform
current
system
appli
univers
qualiti
standard
drug
product
exampl
india
allow
substandard
manufactur
sell
product
africa
fda
could
ban
import
product
india
although
difficult
develop
implement
combin
incent
penalti
driven
polit
econom
level
need
major
urgent
need
improv
qualiti
world
medicin
fall
three
main
area
research
develop
compar
accur
afford
tool
identifi
highqual
drug
point
sale
deploy
best
method
intern
convent
nation
legisl
facilit
product
use
highqual
drug
protect
countri
crimin
neglig
make
distribut
sell
lifethreaten
product
design
highli
qualifi
wellsupport
intern
organ
possibl
fda
establish
standard
train
program
drug
qualiti
surveil
authorit
guidanc
countri
cooper
nation
medic
regulatori
agenc
pharmaceut
compani
intern
agenc
urgent
interest
invest
ensur
patient
throughout
world
access
good
qualiti
medicin
organ
would
also
advoc
strongli
includ
target
achiev
good
qualiti
medicin
mdg
sdg
includ
certif
pharmaceut
product
enter
countri
request
servic
particip
global
diseas
control
elimin
program
